Epstein-Barr virus is (EBV) a ubiquitous virus prevalent in 90% of the human population. Transmitted through infected saliva, EBV is the causative agent of infectious mononucleosis (IM) and is further implicated in malignancies of lymphoid and epithelial origins. In the past few decades, research efforts primarily focused on dissecting the mechanism of EBV-induced oncogenesis. Here, we present an alternate facet of the oncovirus EBV, on its applications in research and therapy. Finally, discussions on the prospective utilization of EBV in nasopharyngeal carcinoma (NPC) diagnosis and therapy will also be presented.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108324 | PMC |
| http://dx.doi.org/10.1016/j.oraloncology.2016.07.010 | DOI Listing |
Publication Analysis
Top Keywords
epstein-barr virus
8
side coin
4
coin leveraging
4
leveraging epstein-barr
4
virus therapy
4
therapy epstein-barr
4
ebv
4
virus ebv
4
ebv ubiquitous
4
ubiquitous virus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!